Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie Erbar

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 19, 2019
A Trans-amplifying RNA Vaccine Strategy for Induction of Potent Protective ImmunityTim Beissert, Mario Perkovic, Annette Vogel, et al.
Nature Nanotechnology|August 11, 2025
Compact polyethylenimine-complexed mRNA vaccinesJorge Moreno Herrero, Theo B Stahl, Stephanie Erbar, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 26, 2017
Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower DosesAnnette B Vogel, Laura Lambert, Ekaterina Kinnear, et al.
Scientific Reports|December 6, 2017
Antigen-specific oncolytic MV-based tumor vaccines through presentation of selected tumor-associated antigens on infected cells or virus-like particlesStefan Hutzler, Stephanie Erbar, Robert A Jabulowsky, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 28, 2022
Self-amplifying RNA vaccine protects mice against lethal Ebola virus infectionVerena Krähling, Stephanie Erbar, Alexandra Kupke, et al.
Molecular Therapy. Nucleic Acids|October 25, 2023
Reducing cell intrinsic immunity to mRNA vaccine alters adaptive immune responses in miceZiyin Wang, Egon J Jacobus, David C Stirling, et al.
Nature Communications|April 26, 2012
Bats host major mammalian paramyxovirusesJan Felix Drexler, Victor Max Corman, Marcel Alexander Müller, et al.
Nature|February 1, 2021
BNT162b vaccines protect rhesus macaques from SARS-CoV-2Annette B Vogel, Isis Kanevsky, Ye Che, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 19, 2019
A Trans-amplifying RNA Vaccine Strategy for Induction of Potent Protective ImmunityTim Beissert, Mario Perkovic, Annette Vogel, et al.
Nature Nanotechnology|August 11, 2025
Compact polyethylenimine-complexed mRNA vaccinesJorge Moreno Herrero, Theo B Stahl, Stephanie Erbar, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 26, 2017
Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower DosesAnnette B Vogel, Laura Lambert, Ekaterina Kinnear, et al.
Scientific Reports|December 6, 2017
Antigen-specific oncolytic MV-based tumor vaccines through presentation of selected tumor-associated antigens on infected cells or virus-like particlesStefan Hutzler, Stephanie Erbar, Robert A Jabulowsky, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 28, 2022
Self-amplifying RNA vaccine protects mice against lethal Ebola virus infectionVerena Krähling, Stephanie Erbar, Alexandra Kupke, et al.
Molecular Therapy. Nucleic Acids|October 25, 2023
Reducing cell intrinsic immunity to mRNA vaccine alters adaptive immune responses in miceZiyin Wang, Egon J Jacobus, David C Stirling, et al.
Nature Communications|April 26, 2012
Bats host major mammalian paramyxovirusesJan Felix Drexler, Victor Max Corman, Marcel Alexander Müller, et al.
Nature|February 1, 2021
BNT162b vaccines protect rhesus macaques from SARS-CoV-2Annette B Vogel, Isis Kanevsky, Ye Che, et al.
Pageof 2